Advancing Human Vaccine Development Using Humanized Mouse Models.
HIV-1
human vaccine
humanized mice
infectious diseases
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
04 Sep 2024
04 Sep 2024
Historique:
received:
13
07
2024
revised:
11
08
2024
accepted:
27
08
2024
medline:
28
9
2024
pubmed:
28
9
2024
entrez:
28
9
2024
Statut:
epublish
Résumé
The development of effective vaccines against infectious diseases remains a critical challenge in global health. Animal models play a crucial role in vaccine development by providing valuable insights into the efficacy, safety, and mechanisms of immune response induction, which guide the design and formulation of vaccines. However, traditional animal models often inadequately recapitulate human immune responses. Humanized mice (hu-mice) models with a functional human immune system have emerged as invaluable tools in bridging the translational gap between preclinical research and clinical trials for human vaccine development. This review summarizes commonly used hu-mice models and advances in optimizing them to improve human immune responses. We review the application of humanized mice for human vaccine development with a focus on HIV-1 vaccines. We also discuss the remaining challenges and improvements needed for the currently available hu-mice models to better facilitate the development and testing of human vaccines for infectious diseases.
Identifiants
pubmed: 39340042
pii: vaccines12091012
doi: 10.3390/vaccines12091012
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : National Key R&D Program
ID : 2023YFC2306600
Organisme : National Natural Science Foundation of China
ID : 82071784
Organisme : Fundamental Research Funds for the Central Universities
ID : 2042022dx0003